bonus
Day 2: Industry reflections & predictions
Welcome to the December Reflections & Predictions series, where weβve gathered voices from our Vitafoods community to discuss the takeaways from 2021 and what to expect in 2022. Tune in for daily updates to fuel your innovative thinking into the new year and beyond.
ππ©πππ€ππ«: Anton OraΕΎem, Chief Executive Officer and Board Member at PharmaLinea and Hermes Consilium
Keep up with our ππππ₯ππππ’π¨π§π¬ & ππ«πππ’πππ’π¨π§π¬ series here: https://feeds.captivate.fm/the-vitafoods-insights/2021-2022-industry-predictions-reflections-/
For more content from Vitafoods Insights, make sure to check our website: https://www.vitafoodsinsights.com/
To learn more about sponsorships opportunities, click here and make sure to check our media kit.
Transcript
Welcome to our December Reflections & Predictions Series. Shall we welcome today's expert?
Anton:Hi, I'm Anton OraΕΎem, CEO of PharmaLinea. Top takeaway for 2021 is that growth shifted significantly from immunity to surrounding lifestyle health areas, like sleep, stress, eye health, bone health, and so forth. In 2022, the area to watch is certainly supply chain security. With all the rising costs and scarcity of the material, the threat we see is companies compromising the quality of raw materials just to be able to secure supply. This could jeopardise the quality, and with that reputation of the whole industry.
